Appili Therapeutics Inc.
APLIF
$0.01
$0.00-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -574.76% | -82.49% | -31.74% | 22.02% | 119.41% |
| Total Depreciation and Amortization | -59.09% | -100.00% | 14.29% | 4.00% | -12.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.77% | -70.44% | -123.29% | -87.51% | 353.27% |
| Change in Net Operating Assets | 252.47% | 148.81% | -55.16% | 1,130.30% | -143.33% |
| Cash from Operations | -129.13% | 36.49% | -283.83% | 95.23% | 312.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 105.79% | 97.83% | -13.16% | 31.54% | -77.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 214.63% | -110.77% | -190.18% | 30.85% | 37.16% |
| Cash from Financing | 304.93% | 469.66% | -78.41% | -112.37% | -11.81% |
| Foreign Exchange rate Adjustments | -103.33% | -221.21% | 14,733.33% | -13,233.33% | 6,971.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.11% | 71.51% | -311.28% | -149.37% | 292.55% |